BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30500330)

  • 1. Biological profiling of piperazinediones for the management of anxiety.
    Kumar D; Gupta SK; Ganeshpurkar A; Singh R; Kumar D; Das N; Krishnamurthy S; Singh SK
    Pharmacol Biochem Behav; 2019 Jan; 176():63-71. PubMed ID: 30500330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiolytic actions of Nardostachys jatamansi via GABA benzodiazepine channel complex mechanism and its biodistribution studies.
    Razack S; Kandikattu HK; Venuprasad MP; Amruta N; Khanum F; Chuttani K; Mishra AK
    Metab Brain Dis; 2018 Oct; 33(5):1533-1549. PubMed ID: 29934858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asparagus racemosus attenuates anxiety-like behavior in experimental animal models.
    Garabadu D; Krishnamurthy S
    Cell Mol Neurobiol; 2014 May; 34(4):511-21. PubMed ID: 24557501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic activity of aqueous extract of
    Shastry R; Ullal SD; Karkala S; Rai S; Gadgade A
    Indian J Pharmacol; 2016; 48(6):681-686. PubMed ID: 28066107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anxiolytic-like effect of rutin in rats involves GABAA receptors in the basolateral amygdala.
    Hernandez-Leon A; González-Trujano ME; Fernández-Guasti A
    Behav Pharmacol; 2017 Jun; 28(4):303-312. PubMed ID: 28145981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice.
    Kuribara H; Stavinoha WB; Maruyama Y
    J Pharm Pharmacol; 1998 Jul; 50(7):819-26. PubMed ID: 9720634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A possible mechanism for anxiolytic and antidepressant effects of alpha- and beta-amyrin from Protium heptaphyllum (Aubl.) March.
    Aragão GF; Carneiro LM; Junior AP; Vieira LC; Bandeira PN; Lemos TL; Viana GS
    Pharmacol Biochem Behav; 2006 Dec; 85(4):827-34. PubMed ID: 17207523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
    Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
    Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance.
    Dalvi A; Rodgers RJ
    Pharmacol Biochem Behav; 1999 Apr; 62(4):727-34. PubMed ID: 10208379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiolytic-like effect of N-n-butyl-3-methoxyquinoxaline-2-carboxamide (60) in experimental mouse models of anxiety.
    Bhatt S; Mahesh R; Devadoss T; Jindal A
    Indian J Exp Biol; 2013 Jul; 51(7):510-4. PubMed ID: 23898549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test.
    Grundmann O; Nakajima J; Seo S; Butterweck V
    J Ethnopharmacol; 2007 Apr; 110(3):406-11. PubMed ID: 17101250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the involvement of the GABAergic, but not serotonergic transmission in the anxiolytic-like effect of bisabolol in the mouse elevated plus maze.
    Tabari MA; Tehrani MAB
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Oct; 390(10):1041-1046. PubMed ID: 28730280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of hippocampal GABA
    Farajdokht F; Vosoughi A; Ziaee M; Araj-Khodaei M; Mahmoudi J; Sadigh-Eteghad S
    Mol Biol Rep; 2020 Sep; 47(9):6487-6496. PubMed ID: 32778988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of anxiolytic activity of compound Valeriana jatamansi Jones in mice.
    You JS; Peng M; Shi JL; Zheng HZ; Liu Y; Zhao BS; Guo JY
    BMC Complement Altern Med; 2012 Nov; 12():223. PubMed ID: 23171285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus effects of positive GABAA modulators and other anxiolytics, sedatives, and anticonvulsants in untreated and diazepam-treated monkeys.
    McMahon LR; France CP
    J Pharmacol Exp Ther; 2003 Jan; 304(1):109-20. PubMed ID: 12490581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil.
    Schmidt-Mutter C; Pain L; Sandner G; Gobaille S; Maitre M
    Eur J Pharmacol; 1998 Jan; 342(1):21-7. PubMed ID: 9544788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracts of kava (Piper methysticum) induce acute anxiolytic-like behavioral changes in mice.
    Garrett KM; Basmadjian G; Khan IA; Schaneberg BT; Seale TW
    Psychopharmacology (Berl); 2003 Oct; 170(1):33-41. PubMed ID: 12845414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of anxiolytic-like effects of some short-acting benzodiazepine hypnotics in mice.
    Nishino T; Takeuchi T; Takechi K; Kamei C
    J Pharmacol Sci; 2008 Jul; 107(3):349-54. PubMed ID: 18603828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice.
    Fernandez SP; Mewett KN; Hanrahan JR; Chebib M; Johnston GA
    Neuropharmacology; 2008 Oct; 55(5):900-7. PubMed ID: 18657554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiolytic-like effects of phytol: possible involvement of GABAergic transmission.
    Costa JP; de Oliveira GA; de Almeida AA; Islam MT; de Sousa DP; de Freitas RM
    Brain Res; 2014 Feb; 1547():34-42. PubMed ID: 24333358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.